Senior insider sale
Senior Vice President, R&D at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$6.33M
96.20K shares
What this filing means
ROTE WILLIAM E. plans to sell 96.20K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $6.33M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001950047-26-009503
Officer· Senior Vice President, R&D
Since Nov 2018
96.20K
Shares to sell
$6.33M
Approx. market value
96.20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Exercise of Stock Options
Cash
9/15/2026
78.65KPerformance Stock Units
N/A
8/13/2021
3.09KRestricted Stock Units
N/A
2/13/2018
5.33KEmployee Stock Purchase Plan
Cash
11/30/2017
9.13KTotal acquired96.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Exercise of Stock Options Cash | 78.65K | — |
8/13/2021 | Performance Stock Units N/A | 3.09K | — |
2/13/2018 | Restricted Stock Units N/A | 5.33K | — |
11/30/2017 | Employee Stock Purchase Plan Cash | 9.13K | — |
| Total | 96.20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
96.20K
Market value
$6.33M
9/15/2026
Total
Units
96.20K
Value
$6.33M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/15/2026 | 96.20K | $6.33M | NASDAQ | Planned |
| Total | 96.20K | $6.33M | ||